Multiple Sclerosis Drug Trial to Reach Next Phase of Testing
Submitted by Pallavi Sharma on Tue, 06/19/2012 - 12:23
New Zealand-based Innate Immunotherapeutic would now be going ahead with next stage of its clinical trials in Australia. The company made this announcement in wake of the success of its earlier tests of MIS416 in patients that are suffering from chronic progressive multiple sclerosis (MS).
Good News USA
